Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy

[1]  G. Xiong,et al.  Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene Network. , 2015, Cancer research.

[2]  Ruedi Aebersold,et al.  Using data‐independent, high‐resolution mass spectrometry in protein biomarker research: Perspectives and clinical applications , 2015, Proteomics. Clinical applications.

[3]  A. Lowe,et al.  Epidermal Growth Factor Receptor (EGFR) Signaling Requires a Specific Endoplasmic Reticulum Thioredoxin for the Post-translational Control of Receptor Presentation to the Cell Surface* , 2015, The Journal of Biological Chemistry.

[4]  Ludovic C. Gillet,et al.  Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps , 2015, Nature Medicine.

[5]  M. Zeng,et al.  Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma. , 2014, The Journal of surgical research.

[6]  G. Chiappetta,et al.  Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells , 2014, Molecular Cancer.

[7]  M. Parat,et al.  PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis , 2013, Oncotarget.

[8]  P. Meltzer,et al.  Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse model. , 2013, Carcinogenesis.

[9]  A. Harris,et al.  Collagen XV: Exploring Its Structure and Role within the Tumor Microenvironment , 2013, Molecular Cancer Research.

[10]  R. Iozzo,et al.  Decorin causes autophagy in endothelial cells via Peg3 , 2013, Proceedings of the National Academy of Sciences.

[11]  Darya Chudova,et al.  Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. , 2012, The New England journal of medicine.

[12]  R. Iozzo,et al.  Decorin: a guardian from the matrix. , 2012, The American journal of pathology.

[13]  R. Ralhan,et al.  Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness , 2012, PloS one.

[14]  Dana Pascovici,et al.  PloGO: Plotting gene ontology annotation and abundance in multi‐condition proteomics experiments , 2012, Proteomics.

[15]  Ludovic C. Gillet,et al.  Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis* , 2012, Molecular & Cellular Proteomics.

[16]  C. Larsson,et al.  Proteomic profiling of follicular and papillary thyroid tumors , 2011, European journal of endocrinology.

[17]  Marina N. Nikiforova,et al.  Molecular genetics and diagnosis of thyroid cancer , 2011, Nature Reviews Endocrinology.

[18]  S. Asa,et al.  Molecular pathology of thyroid cancer , 2011 .

[19]  G. Lippi,et al.  The spectrum of coagulation abnormalities in thyroid disorders. , 2011, Seminars in thrombosis and hemostasis.

[20]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[21]  C. Larsson,et al.  Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma. , 2010, Thyroid : official journal of the American Thyroid Association.

[22]  Matthias Mann,et al.  Mass spectrometry–based proteomics in cell biology , 2010, The Journal of cell biology.

[23]  Matthias Mann,et al.  Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. , 2009, Journal of proteome research.

[24]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[25]  E. Cibas,et al.  The Bethesda System for Reporting Thyroid Cytopathology , 2009, Springer International Publishing.

[26]  J. O'flaherty,et al.  Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways. , 2009, Neoplasia.

[27]  S. Asa,et al.  Application of immunohistochemistry to thyroid neoplasms. , 2009, Archives of pathology & laboratory medicine.

[28]  M. Fassan,et al.  An antimetastatic role for decorin in breast cancer. , 2008, The American journal of pathology.

[29]  B. Haugen,et al.  Discovery and validation of protein abundance differences between follicular thyroid neoplasms. , 2008, Cancer research.

[30]  Zheng Wang,et al.  The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. , 2008, Cancer research.

[31]  H. Gharib,et al.  Thyroid nodules: clinical importance, assessment, and treatment. , 2007, Endocrinology and metabolism clinics of North America.

[32]  Krzysztof Fujarewicz,et al.  A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping , 2007, Endocrine-related cancer.

[33]  R. Chiquet‐Ehrismann,et al.  Tenascin-C induced signaling in cancer. , 2006, Cancer letters.

[34]  Z. Werb,et al.  Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A. , 2006, Endocrine-related cancer.

[35]  Matthew D. Welch,et al.  The ARP2/3 complex: an actin nucleator comes of age , 2006, Nature Reviews Molecular Cell Biology.

[36]  K. Shroyer,et al.  Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue , 2006, Molecular carcinogenesis.

[37]  S. Asa,et al.  Pathogenetic mechanisms in thyroid follicular-cell neoplasia , 2006, Nature Reviews Cancer.

[38]  Liliane A. T. Arnaldi,et al.  Gene expression profiles reveal that DCN, DIO1, and DIO2 are underexpressed in benign and malignant thyroid tumors. , 2005, Thyroid : official journal of the American Thyroid Association.

[39]  K. Iwaya,et al.  Involvement of Arp2/3 complex in the process of colorectal carcinogenesis , 2004, Modern Pathology.

[40]  R. Iozzo,et al.  In vivo selective and distant killing of cancer cells, using adenovirus‐mediated decorin gene transfer , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  R. Iozzo,et al.  Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin , 2002, Oncogene.

[42]  B. Haugen,et al.  Towards improving the utility of fine‐needle aspiration biopsy for the diagnosis of thyroid tumours , 2002, Clinical endocrinology.

[43]  A. Otto,et al.  beta-Thymosins, small acidic peptides with multiple functions. , 2001, The international journal of biochemistry & cell biology.

[44]  H. Iwase,et al.  Clinical significance of E‐cadherin expression in thyroid neoplasms , 2001, Journal of surgical oncology.

[45]  G. Viglietto,et al.  Thymosin β-10 Gene Overexpression Correlated with the Highly Malignant Neoplastic Phenotype of Transformed Thyroid Cells in Vivo and in Vitro , 1998 .

[46]  I. Weber,et al.  Model Structure of Decorin and Implications for Collagen Fibrillogenesis* , 1996, The Journal of Biological Chemistry.

[47]  W. Birchmeier,et al.  Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. , 1994, Biochimica et biophysica acta.

[48]  G. Brabant,et al.  E-cadherin: a differentiation marker in thyroid malignancies. , 1993, Cancer research.

[49]  T. D. Hamilton,et al.  Classification of Tumours , 1930, Edinburgh medical journal.

[50]  Craig R Moores,et al.  H-40, an antigen controlled by an Igh linked gene and recognized by cytotoxic T lymphocytes. I. Genetic analysis of H-40 and distribution of its product on B cell tumors , 1984, The Journal of experimental medicine.

[51]  M. Molloy,et al.  T E C H N I C a L a D V a N C E Open Access , 2022 .

[52]  M. Götte,et al.  More than matrix: the multifaceted role of decorin in cancer. , 2013, European journal of cell biology.

[53]  Jacques Ferlay,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .

[54]  G. Viglietto,et al.  Thymosin beta-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro. , 1998, Cancer research.

[55]  E. Somers.  International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.